Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Open-Heart Surgery Best for Patients with Multiple Blockages

By HospiMedica International staff writers
Posted on 14 May 2019
A new study suggests that coronary artery bypass grafting (CABG) surgery may be the best treatment option for most patients with multi-vessel coronary artery disease (MVCAD).

Researchers at the University of Pittsburgh Medical Center (UPMC; PA, USA) conducted a retrospective study that examined data from two major clinical outcome registries for heart patients in order to identify UPMC patients with MVCAD who underwent either CABG or percutaneous coronary intervention (PCI) between 2010 and 2018. More...
Patients who met eligibility criteria were separated into two groups, CABG and PCI, with each including 844 patients. The main outcomes and measures were mortality, readmission, and revascularization.

The study revealed that estimated one-year mortality was 11.5% for the PCI group and 7.2% for the CABG group, for an overall hazard ratio for mortality of PCI versus CABG of 1.64. The researchers also found that the overall hazard ratio for readmission was 1.42, while the overall hazard ratio for repeat revascularization for PCI was 4.06. The CABG group also experienced a lower risk of hospital readmission (28.1% versus 38.4%) and revascularization (one percent in the CABG group, versus 6.7 in the PCI group). The study was published on May 1, 2019, in The Annals of Thoracic Surgery.

“Our data demonstrate a significant mortality benefit with CABG over PCI, and this benefit is consistent across virtually all major patient groups, suggesting that CABG should be considered in broader patient populations, not just in cases of patients with diabetes and left ventricular dysfunction,” said lead author Suresh Mulukutla, MD. “Because of this, it is important to deliberate carefully with the help of a heart team. The team can ensure that a multidisciplinary approach is used when offering recommendations to patients and assisting them in making informed decisions."

For patients with coronary artery disease, CABG can be placed to reroute blood around blocked arteries in order to restore and improve oxygen supply to the heart. To create the bypass graft, healthy blood vessels are used from other parts of the body, most often from the patient's leg or arm. The harvested vessel thus becomes the bypass graft, with one end attaching to a blood source above and the other end below the blocked area, creating a new conduit channel.

Related Links:
University of Pittsburgh Medical Center


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.